568 related articles for article (PubMed ID: 15606374)
21. Loss of nuclear expression of parafibromin distinguishes parathyroid carcinomas and hyperparathyroidism-jaw tumor (HPT-JT) syndrome-related adenomas from sporadic parathyroid adenomas and hyperplasias.
Gill AJ; Clarkson A; Gimm O; Keil J; Dralle H; Howell VM; Marsh DJ
Am J Surg Pathol; 2006 Sep; 30(9):1140-9. PubMed ID: 16931959
[TBL] [Abstract][Full Text] [Related]
22. Intraoperative parathormone measurement in patients with multiple endocrine neoplasia type I syndrome and hyperparathyroidism.
Tonelli F; Spini S; Tommasi M; Gabbrielli G; Amorosi A; Brocchi A; Brandi ML
World J Surg; 2000 May; 24(5):556-62; discussion 562-3. PubMed ID: 10787076
[TBL] [Abstract][Full Text] [Related]
23. Novel parathyroid hormone (1-84) assay as basis for parathyroid hormone monitoring in renal hyperparathyroidism.
Kaczirek K; Prager G; Riss P; Wunderer G; Asari R; Scheuba C; Bieglmayer C; Niederle B
Arch Surg; 2006 Feb; 141(2):129-34; discussion 134. PubMed ID: 16490888
[TBL] [Abstract][Full Text] [Related]
24. Long-term results of less than total parathyroidectomy for hyperparathyroidism in multiple endocrine neoplasia type 1.
Arnalsteen LC; Alesina PF; Quiereux JL; Farrel SG; Patton FN; Carnaille BM; Cardot-Bauters CM; Wemeau JL; Proye CA
Surgery; 2002 Dec; 132(6):1119-24; discussion 1124-5. PubMed ID: 12490864
[TBL] [Abstract][Full Text] [Related]
25. Serum calcium, parathyroid hormone, and urinary cyclic adenosine monophosphate after parathyroidectomy.
Kaplan EL; Fang VS; Sugimoto J; Fredland A
Surgery; 1982 Nov; 92(5):822-6. PubMed ID: 6291182
[TBL] [Abstract][Full Text] [Related]
26. Reoperation for hyperparathyroidism in multiple endocrine neoplasia type 1.
Kivlen MH; Bartlett DL; Libutti SK; Skarulis MC; Marx SJ; Simonds WF; Weinstein LS; Jensen RT; McCart JA; Naik AM; Kranda KC; Brennan MF; Norton JA; Fraker DL; Alexander HR
Surgery; 2001 Dec; 130(6):991-8. PubMed ID: 11742328
[TBL] [Abstract][Full Text] [Related]
27. Long-term outcome of patients with elevated parathyroid hormone levels after successful parathyroidectomy for sporadic primary hyperparathyroidism.
Solorzano CC; Mendez W; Lew JI; Rodgers SE; Montano R; Carneiro-Pla DM; Irvin GL
Arch Surg; 2008 Jul; 143(7):659-63; discussion 663. PubMed ID: 18645108
[TBL] [Abstract][Full Text] [Related]
28. Strategy and technique of reoperative parathyroid surgery.
Saxe AW; Brennan MF
Surgery; 1981 Apr; 89(4):417-23. PubMed ID: 7209789
[TBL] [Abstract][Full Text] [Related]
29. Parathyroid "double adenomas": fact of fiction?
Verdonk CA; Edis AJ
Surgery; 1981 Sep; 90(3):523-6. PubMed ID: 6115478
[TBL] [Abstract][Full Text] [Related]
30. Primary hyperparathyroidism in pediatric patients.
Kollars J; Zarroug AE; van Heerden J; Lteif A; Stavlo P; Suarez L; Moir C; Ishitani M; Rodeberg D
Pediatrics; 2005 Apr; 115(4):974-80. PubMed ID: 15805373
[TBL] [Abstract][Full Text] [Related]
31. Minimally invasive parathyroidectomy without intraoperative parathyroid hormone monitoring in patients with primary hyperparathyroidism.
Mihai R; Palazzo FF; Gleeson FV; Sadler GP
Br J Surg; 2007 Jan; 94(1):42-7. PubMed ID: 17083106
[TBL] [Abstract][Full Text] [Related]
32. Minimally invasive parathyroid surgery for recurrent intrathyroid multiple endocrine neoplasia (MEN).
Turner M; Balan KK; O'Rahilly S; Wishart GC
Ann R Coll Surg Engl; 2004 Nov; 86(6):W52-3. PubMed ID: 16749969
[TBL] [Abstract][Full Text] [Related]
33. Molecular pathogenesis of primary hyperparathyroidism.
Cetani F; Pardi E; Borsari S; Marcocci C
J Endocrinol Invest; 2011 Jul; 34(7 Suppl):35-9. PubMed ID: 21985978
[TBL] [Abstract][Full Text] [Related]
34. Parathyroid mitogenic activity in plasma from patients with familial multiple endocrine neoplasia type 1.
Brandi ML; Aurbach GD; Fitzpatrick LA; Quarto R; Spiegel AM; Bliziotes MM; Norton JA; Doppman JL; Marx SJ
N Engl J Med; 1986 May; 314(20):1287-93. PubMed ID: 2871488
[TBL] [Abstract][Full Text] [Related]
35. [Hereditary variants of primary hyperparathyroidism--MEN1, MEN2, HPT-JT, FHH, FIHPT].
Frank-Raue K; Leidig-Bruckner G; Lorenz A; Rondot S; Haag C; Schulze E; Büchler M; Raue F
Dtsch Med Wochenschr; 2011 Sep; 136(38):1889-94. PubMed ID: 21915802
[TBL] [Abstract][Full Text] [Related]
36. Primary hyperparathyroidism in patients with multiple endocrine neoplasia type 1: comparison with sporadic parathyroid adenomas.
Katai M; Sakurai A; Ikeo Y; Hashizume K
Horm Metab Res; 2001 Aug; 33(8):499-503. PubMed ID: 11544565
[TBL] [Abstract][Full Text] [Related]
37. Recurrent hyperparathyroidism due to parathyroid autografts: incidence, presentation, and management.
Demeter JG; De Jong SA; Lawrence AM; Paloyan E
Am Surg; 1993 Mar; 59(3):178-81. PubMed ID: 8476157
[TBL] [Abstract][Full Text] [Related]
38. A follow-up study of patients with MEN syndromes - five case reports.
Buła G; Truchanowski W; Koziołek H; Polczyk J; Ziora P; Gawrychowski J
Endokrynol Pol; 2018; 69(2):163-167. PubMed ID: 29952424
[TBL] [Abstract][Full Text] [Related]
39. Reoperation for persistent or recurrent primary hyperparathyroidism.
Mariette C; Pellissier L; Combemale F; Quievreux JL; Carnaille B; Proye C
Langenbecks Arch Surg; 1998 Apr; 383(2):174-9. PubMed ID: 9641894
[TBL] [Abstract][Full Text] [Related]
40. Hypercalcemia in the multiple endocrine neoplasia syndromes.
Fitzpatrick LA
Endocrinol Metab Clin North Am; 1989 Sep; 18(3):741-52. PubMed ID: 2570692
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
